You are seeing these quotes based on previous browsing related to sectors such as
Name | Traded | Action | Notifier | Last | Amount | Value |
---|---|---|---|---|---|---|
GSK | 16-Apr-24 | Buy Dividends | Hal Barron | $39.79 | 2,906,213 | $95,366,062.48 |
GSK | 16-Apr-24 | Buy Dividends | Emma Walmsley | 1,611.28p | 1,840,922 | £29,662,409.10 |
Destiny Pharma | 02-Aug-24 | Buy | Nigel Rudd | 250.00p | 1,240,000 | £3,100,000.00 |
Oxford Nanopore Technologies | 15-Oct-24 | Sell | Gurdial (Gordon) Sanghera | 141.66p | 1,993,571 | £2,824,112.62 |
Bioventix | 29-Jan-24 | Sell | Peter John Harrison | 4,200.00p | 62,000 | £2,604,000.00 |
GSK | 16-Feb-24 | Sell | Emma Walmsley | 1,657.97p | 139,792 | £2,317,709.49 |
AstraZeneca | 14-Nov-24 | Buy | Pascal Soriot | 10,203.00p | 20,000 | £2,040,599.98 |
Animalcare Group | 05-Dec-24 | Buy | Marc Coucke | 232.50p | 860,213 | £1,999,995.27 |
Indivior | 14-Mar-24 | Sell | Mark Crossley | 1,630.00p | 91,204 | £1,486,625.13 |
Haleon | 01-Mar-24 | Sell | Brian McNamara | $8.43 | 168,135 | $1,168,210.85 |
Oxford Nanopore Technologies | 28-Jun-24 | Sell | Gurdial (Gordon) Sanghera | 91.64p | 1,203,967 | £1,103,357.50 |
OptiBiotix Health | 17-Dec-24 | Exercise of option | Stephen O'Hara | 16.00p | 6,099,135 | £975,861.58 |
Argent Biopharma Limited NPV (DI) | 15-Oct-24 | Placing | Roby Zomer | $0.41 | 4,000,000 | $868,046.36 |
4basebio | 15-Nov-24 | Buy | Heikki Lanckriet | 1,325.00p | 46,500 | £616,125.00 |
4basebio | 15-Nov-24 | Sell | Heikki Lanckriet | 1,325.00p | 46,500 | £616,125.00 |
PureTech Health | 24-Jun-24 | Sell | Robert Langer | 250.00p | 233,098 | £582,745.00 |
Avacta Group | 30-Aug-24 | Sell | Tony Peter Gardiner | 71.07p | 500,000 | £355,349.99 |
Genus | 16-Sep-24 | Sell | Jorgen Kokke | 1,956.97p | 16,876 | £330,258.26 |
Genus | 16-Sep-24 | Sell | Dan Hartley | 56,400.00p | 564 | £318,096.00 |
GSK | 01-Feb-24 | Buy | Julie Brown | 1,582.80p | 19,360 | £306,430.08 |